Delivery Order SPE2DB22D1106-SPE2DB25FDPP9

Award Date 12/9/24
Potential Completion Date 12/10/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDPP9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,559.53 Firm Fixed Price delivery order (SPE2DB22D1106|SPE2DB25FDPP9) is for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM, a respiratory medication. The contract has an ultimate completion date of December 10, 2024 and does not include any set-aside designation, indicating open competition.

Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) relevant to this award - a $999,999,999 IDC with the DLA Troop Support Medical through November 2026, and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024. These IDCs serve as primary vehicles for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs, federal law enforcement, and other government medical institutions.

Generated 3/16/25, 12:56 AM